under

Revolution Medicines Awarded Voucher for Daraxonrasib (RMC-6236) Under FDA Commissioner’s National Priority Voucher Pilot Program

REDWOOD CITY, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing…

3 months ago

Advanced Instruments is Now Merged Under the Nova Biomedical Name: One Unified Brand Driving Innovation

WALTHAM, Mass., Oct. 15, 2025 /PRNewswire/ -- We are proud to announce that Advanced Instruments and Nova Biomedical are now…

3 months ago

ZTE hosts Global Summit & User Congress 2025 in Milan under the theme “Expanding Intelligence, Creating Possibilities”

MILAN, Oct. 9, 2025 /PRNewswire/ -- ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of integrated information and communication…

3 months ago

Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 10, 2025 16:41 ET  | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals,…

3 months ago

Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

October 10, 2025 17:16 ET  | Source: Bluejay Diagnostics, Inc. ACTON, Mass., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics,…

3 months ago

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

October 03, 2025 16:01 ET  | Source: BridgeBio Pharma, Inc. PALO ALTO, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- BridgeBio…

3 months ago

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 03, 2025 16:01 ET  | Source: Intellia Therapeutics, Inc. CAMBRIDGE, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics,…

3 months ago

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 01, 2025 17:20 ET  | Source: ZENTALIS PHARMACEUTICALS SAN DIEGO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc.…

3 months ago

Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases

September 29, 2025 19:30 ET  | Source: Nxera Pharma Tokyo, Japan and Cambridge and London, UK, 30 September 2025 –…

3 months ago

Superiorstar Prosperity Group under Russell Hawthorne implements neural network models

New York, NY, Sept. 27, 2025 (GLOBE NEWSWIRE) -- Announcement and strategic context Superiorstar Prosperity Group detailed a technology upgrade…

3 months ago